Table 1 Number, proportion and mean age of patients in the different clinical categories of COVID-19 severity in the SCOURGE study, with and without detectable mCAs or LOY (males)

From: Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

  

Asymphthomatic (0)

Mild (1)

Moderate (2)

Severe (3)

Critical (4)

Subtotal

No data

Deada

Alivea

Subtotal

Total

 

Cohort (no mCA)

cases

607

2727

2141

2449

1157

9081

494

810

8054

8864

9445

9578

(%)

(6.7)

(30.0)

(23.6)

(27.0)

(12.7)

(9.1)

(90.9)

age

53.3

51.3

66.9

70.6

65.4

  

79.9

60.5

  

mCAs

cases

4

18

34

46

17

119

14

29

90

119

133

(%)

(3.4)

(15.1)

(28.6)

(38.7)

(14.3)

(24.4)

(75.6)

age

80.9

65.6

78.2

79.5

71.4

  

81.1

74.1

  

males

2

7

18

18

15

61

8

18

42

60

69

(%)

(3.3)

(11.5)

(29.5)

(29.5)

(24.6)

(30.0)

(70.0)

age

80.5

73.9

76.7

78.1

70.5

  

80.7

72.1

 

75.4

females

2

10

16

27

2

58

6

11

48

59

64

(%)

(3.4)

(17.2)

(27.6)

(46.6)

(3.4)

(18.6)

(81.4)

age

81

60.1

79.7

79.8

72.5

  

80.6

75.4

 

76.5

Males (no LOY)

cases

163

743

1068

1241

792

4007

323

398

3494

3892

4218

4444

(%)

(4.1)

(18.5)

(26.7)

(31.0)

(19.8)

(10.2)

(89.8)

age

53.2

51.9

64.8

69.1

64.0

  

77.2

61.5

  

Males LOY

cases

4

13

47

97

47

208

18

65

143

208

226

(%)

(1.9)

(6.3)

(22.6)

(46.6)

(22.6)

(31.3)

(68.8)

age

81.2

78.5

81.0

83.5

79.3

  

84.1

81.5

  
  1. a>90 days after COVID-19.